Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

Centre Hospitalier Universitaire de Nīmes2,787 enrolled

Overview

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Study Type

OBSERVATIONAL

Enrollment

2,787

Conditions

Intensive Care

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Intensive Care Unit patients on weekdays

Outcomes

Primary Outcomes

Length of hospital stay

Time frame: expected average of 20 days

Secondary Outcomes

Intensive Care Unit length of stay

Time frame: Expected maximum of 10 days

Mechanical ventilation duration

Time frame: Expected maximum of 10 days

Intensive care unit mortality rate

Time frame: Expected maximum of 10 days

Hospital mortality rate

Time frame: End of hospital stay (expected average of 20 days)

Patient cost expenditure

Time frame: End of hospital stay (expected average of 20 days)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.